Accelerating Progress in Cancer Research and Development
Accelerating Progress in Cancer Research and Development
LLS supports robust federal funding dedicated to cancer research. We also aim to enact policies that enhance clinical trials, promote drug development and focus on what matters most to patients.
“One of the biggest misconceptions with pediatric cancer is that once the treatments are finished, the battle is over. The consequences of the toxic therapies injected into little bodies can cause serious and sometimes life-threatening complications years later.”
- Michelle Marks, mom of pediatric cancer patient
Our Work
Increasing Funding for Cancer Research
As an organization that has funded more than $1.2 billion in cancer research, LLS knows firsthand the importance of funding research in order to one day achieve a world without blood cancers. But we can't do it alone. That's why we advocate for public funding for cancer research to bring us closer to life-saving treatments and cures.
Strengthening the FDA
The U.S. Food & Drug Administration’s (FDA) mission has always centered on promoting and protecting the public’s health. LLS holds FDA accountable to its commitment to accelerating patient access to innovative cancer treatments that are both safe and effective.
Accelerating New Treatments for Pediatric Patients
When it comes to childhood cancers, regulators often approach kids as if they’re tiny adults. But the biology of pediatric cancers is typically distinct from adults’, making targeted research critical.